Pharmidex Information

Pharmidex is a UK-based, GLP and GCP-compliant preclinical Contract Research Organisation (CRO) founded in 2002. We generate high-quality, regulator-ready data packages to support global drug development programmes, operating under established UK regulatory frameworks with rigorous quality systems and full data traceability. Pharmidex is also AAALAC accredited, reflecting our commitment to the highest standards of animal welfare and scientific integrity. Our integrated capabilities include: • Drug Metabolism & Pharmacokinetics (DMPK) • Bioanalysis (GLP / GCP / non-GLP) • Toxicology (GLP & non-GLP) • In vivo pharmacology and efficacy models • Histology, clinical chemistry & haematology • In vitro ADME • In silico modelling We support programmes across oncology, CNS, respiratory, stroke, autoimmune and metabolic diseases. With over 400 global clients and more than 17,000 completed studies, Pharmidex has built a reputation for delivering robust, defensible data that withstands regulatory scrutiny. All work is conducted in the UK, providing sponsors with confidence in compliance, oversight, and scientific accountability, an increasingly important differentiator in global development. Beyond fee-for-service research, we are active partners in translational and grant-funded programmes, having participated in 37+ international collaborations with over 170 global partners.